ArticleFrontiers in immunology2026

FGFR1 copy number gain is independently associated with shorter progression-free survival in advanced lung squamous cell carcinoma treated with first-line immune checkpoint inhibitor-based therapy.

Shuya Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.